Biotech

All Articles

8 months after a $213M fundraise, genetics editor Volume helps make decreases

.After raising $213 million in 2023-- one of the year's most extensive private biotech shots-- Volum...

BioMarin creates director team with biotech veterinarians-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of considerable management hirings, firings a...

Biopharma Q2 VC struck highest level due to the fact that '22, while M&ampA slowed down

.Financial backing financing into biopharma rose to $9.2 billion across 215 sell the 2nd one-fourth ...

Bicara, Zenas look for IPOs to drive late-phase assets toward market

.Bicara Therapeutics as well as Zenas Biopharma have actually supplied fresh incentive to the IPO ma...

Genentech to shut cancer cells immunology investigation department

.Genentech will definitely shut its cancer immunology study team, and system head as well as promine...

Kezar loses strong growth but to verify its worth in phase 1 trial

.Kezar Life Sciences is actually dropping its dim stage 1 strong lump medicine as the biotech goes a...

Acelyrin drops izokibep, drops 3rd of workers

.Despite izokibep maintaining its newly found winning touch in the facility, Acelyrin is actually no...

Rivus' period 2 obesity-related cardiac arrest trial hits endpoint

.Rivus Pharmaceuticals has actually plumped up the potential customers of its fat-busting, muscle-sp...

Ovid stops preclinical work, IV program after soticlestat fall short

.Ovid Rehab currently revealed final month that it was actually trimming its head count as the provi...

Eli Lilly opens up $700M nucleic acid R&ampD facility in Boston ma Port

.Eli Lilly has actually opened a $700 million R&ampD center in the Boston Port, boosting its own RNA...